---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-069098"
form_type: "8-K"
ticker: "CYTK"
cik: "0001061983"
company_name: "CYTOKINETICS INC"
filed_at: "2024-06-05T23:59:59+00:00"
generated_at: "2026-06-01T06:10:06.205928+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Cytokinetics discloses third-party acquisition approach, no deal reached

## Summary
- Cytokinetics was approached by a third party for a full acquisition after SEQUOIA-HCM top-line results in Dec 2023.
- Board supported moving forward on substantially agreed terms, but the third party did not proceed.
- CEO states Board and management are committed to shareholder value and would support any value-maximizing transaction.
- Company will not comment further on this matter.

## SEC filing metadata
- accession: 0000950170-24-069098
- form_type: 8-K
- ticker: CYTK
- cik: 0001061983
- company_name: CYTOKINETICS INC
- filed_at: 2024-06-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1061983/000095017024069098/0000950170-24-069098-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1061983/000095017024069098/cytk-20240605.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-069098
- JSON: https://secwatch.observer/filing/0000950170-24-069098.json
- Plain text: https://secwatch.observer/filing/0000950170-24-069098.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.